Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein InvasionMinke He, Ming Shi, Wanqiang Fang et al.|JAMA Oncology|2019Cited by 559
Target lesion response predicts survival of patients with hepatocellular carcinoma retreated with transarterial chemoembolizationYong‐Fa Zhang, Ming Shi, Rong Guo et al.|Liver International|2016Cited by 1